These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31668448)

  • 1. Estimated Glomerular Filtration Rate, Activation of Cardiac Biomarkers and Long-Term Cardiovascular Outcomes: A Population-Based Cohort.
    Vinnakota S; Scott CG; Rodeheffer RJ; Chen HH
    Mayo Clin Proc; 2019 Nov; 94(11):2189-2198. PubMed ID: 31668448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure.
    Aimo A; Januzzi JL; Vergaro G; Ripoli A; Latini R; Masson S; Magnoli M; Anand IS; Cohn JN; Tavazzi L; Tognoni G; Gravning J; Ueland T; Nymo SH; Rocca HB; Bayes-Genis A; Lupón J; de Boer RA; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Tentzeris I; Wilson Tang WH; Grodin JL; Passino C; Emdin M
    Int J Cardiol; 2019 Feb; 277():166-172. PubMed ID: 30416028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.
    Bansal N; Zelnick L; Shlipak MG; Anderson A; Christenson R; Deo R; deFilippi C; Feldman H; Lash J; He J; Kusek J; Ky B; Seliger S; Soliman EZ; Go AS;
    Clin Chem; 2019 Nov; 65(11):1448-1457. PubMed ID: 31578216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease.
    Bjurman C; Petzold M; Venge P; Farbemo J; Fu ML; Hammarsten O
    Clin Biochem; 2015 Mar; 48(4-5):302-7. PubMed ID: 25637776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular Filtration Rate-Specific Cutoffs Can Refine the Prognostic Value of Circulating Cardiac Biomarkers in Advanced Chronic Kidney Disease.
    Canney M; Tang M; Er L; Barbour SJ; Djurdjev O; Levin A;
    Can J Cardiol; 2019 Sep; 35(9):1106-1113. PubMed ID: 31472810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease.
    Tsai YC; Tsai HJ; Lee CS; Chiu YW; Kuo HT; Lee SC; Chen TH; Kuo MC
    PLoS One; 2018; 13(8):e0202733. PubMed ID: 30133531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
    Sundqvist S; Larson T; Cauliez B; Bauer F; Dumont A; Le Roy F; Hanoy M; Fréguin-Bouilland C; Godin M; Guerrot D
    PLoS One; 2016; 11(8):e0159914. PubMed ID: 27548064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT.
    Ascher SB; Berry JD; Katz R; de Lemos JA; Bansal N; Garimella PS; Hallan SI; Wettersten N; Jotwani VK; Killeen AA; Ix JH; Shlipak MG
    Am J Kidney Dis; 2024 May; 83(5):615-623.e1. PubMed ID: 37992982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proBNP level in stage 3-4 chronic kidney disease and mortality in long-term follow-up: HAPPY study subgroup analysis.
    Şimşek MA; Değertekin M; Türer Cabbar A; Hünük B; Aktürk S; Erdoğmuş S; Mutlu B; Kozan Ö
    Turk Kardiyol Dern Ars; 2020 Jul; 48(5):454-460. PubMed ID: 32633264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
    Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD.
    Bansal N; Zelnick LR; Ballantyne CM; Chaves PHM; Christenson RH; Coresh J; deFilippi CR; de Lemos JA; Daniels LB; Go AS; He J; Hedayati SS; Matsushita K; Nambi V; Shlipak MG; Taliercio JJ; Seliger SL;
    Am J Kidney Dis; 2022 Mar; 79(3):383-392. PubMed ID: 34293394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
    Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
    Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
    Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
    Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
    Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Incident Atrial Fibrillation in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study.
    Zelnick LR; Shlipak MG; Soliman EZ; Anderson A; Christenson R; Lash J; Deo R; Rao P; Afshinnia F; Chen J; He J; Seliger S; Townsend R; Cohen DL; Go A; Bansal N
    Clin J Am Soc Nephrol; 2021 Jul; 16(7):1015-1024. PubMed ID: 34597264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.